XTRA:SHLMedical Equipment
Assessing Siemens Healthineers (XTRA:SHL) Valuation After New Imaging Clearance And Irish R&D Expansion
Siemens Healthineers (XTRA:SHL) has been back in focus after the U.S. FDA cleared its Biograph One PET/MR scanner and the company opened a new €10m immunoassay R&D centre in Ireland.
See our latest analysis for Siemens Healthineers.
Despite the recent product clearances and new R&D investment, Siemens Healthineers’ 90 day share price return of 14.03% decline and 1 year total shareholder return of 20.33% loss suggest momentum has been weak, with recent news now testing that trend.
If this...